Home
Storia in 2 fonti
U.S. pharma tariffs spare India’s generic drugmakers — but leave investors jittery
Investors of Indian pharmaceutical companies are worried about the prospect of further escalation amid U.S. trade tensions.
- ·
cnbc.com
Asian pharma stocks extend declines after Trump slaps 100% levies on branded drugs
The 100% duties apply to "any branded or patented Pharmaceutical Product" except for companies that build manufacturing plants in the U.S., Trump said Friday.
- ·
thehindu.com
Trump Tariffs: US President announces 100% tariff on drugs effective October 1; generics spared but India braces for fallout
U.S. President Donald Trump announces 100% tariff on branded pharmaceutical imports, pushing for U.S. manufacturing, impacting India's $20 billion industry.
- ·
U.S. pharma tariffs spare India’s generic drugmakers — but leave investors jittery
Investors of Indian pharmaceutical companies are worried about the prospect of further escalation amid U.S. trade tensions.